Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 8 EP applications Julia Anne Florence has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11755042

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 9/14, A61K 31/137, A61K 31/58, A61P 11/06
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13803046

COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS

IPC classification:
A61K 9/00, A61K 9/10, A61K 31/4418, A61K 31/58, A61K 47/38
Applicant:
Glaxo Group Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15172604

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 9/14, A61K 31/133, A61K 31/137, A61K 31/58, A61P 11/06
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12744272

CATHEPSIN C INHIBITORS

IPC classification:
A01N 43/16, A61K 31/35, C07D 309/14, C07D 405/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755043

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 9/14, A61K 31/133, A61K 31/137, A61K 31/58, A61P 11/06
Applicant:
GlaxoSmithKline Intellectual Property Limited
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
PATENT GRANTED
EP15794976

LONG ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C

IPC classification:
A61K 9/00, A61K 31/343, A61K 47/26, A61K 47/32, C12N 15/113
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
Request for examination was made
EP15791372

LONG ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C

IPC classification:
A61K 9/00, A61K 31/343, A61K 31/69, A61K 31/7088, A61K 47/26, A61P 31/14, C12N 15/113
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
Request for examination was made
EP15791373

COMBINATION LONG ACTING COMPOSITIONS AND METHODS FOR HEPATITIS C

IPC classification:
A61K 9/00, A61K 31/7088, A61K 47/26, A61P 31/14, C12N 15/113
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature